Post-COVID Pediatric Budd-Chiari Syndrome

Main Article Content

Dhan Raj Bagri
Naresh Bairwa
JN Sharma


Introduction: Budd-Chiari syndrome (BCS) is rare in children. Underlying etiologies, natural history and management differ in children and adults. Treatment options like liver transplantation and transjugular intrahepatic portosystemic shunt have also been less well-studied in children. Presented here is the case of a male child with BCS after coronavirus disease 2019 (COVID-19) infection. Case presentation: A 3-year-old male child presented with complaints of gradually increasing abdominal distension, constipation, decreased urine output, visible veins over abdomen and swelling in lower limbs and periorbital edema since last 15 days. He was diagnosed as BCS after multiple imaging investigations, including triple phase contrast-enhanced computed tomography (CECT) abdomen. His COVID antibody tested positive. Conclusion: Practice guidelines for children with BCS should be formulated, expert group recommendations should be reviewed and a consensus statement should be issued. Underlying etiology remains obscure despite extensive work-up in most of the children. Association of COVID-19 with BCS may be incidental but should be studied further as COVID is known to cause thrombotic complications.

Article Details

How to Cite
Dhan Raj Bagri, Naresh Bairwa, & JN Sharma. (2022). Post-COVID Pediatric Budd-Chiari Syndrome. Indian Journal Of Clinical Practice, 32(9), 30–33. Retrieved from
Case Report